# OUP Management Co., LLC

> Institutional holdings reported to the SEC as of Q3 2023 on Form 13F. CIK 1880124. Source: https://holderbook.com/funds/1880124-oup-management-co-llc/

- Reported value: $44.5M
- Positions: 12
- Weight of the ten largest: 99.6%
- Filed: 2023-11-09

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| CENTESSA PHARMACEUTICALS PLC | [CNTA](https://holderbook.com/stocks/CNTA/) | $19.0M | 2,937,615 | 42.7% | 8 |
| AEROVATE THERAPEUTICS INC | [AVTE](https://holderbook.com/stocks/AVTE/) | $8.2M | 603,762 | 18.4% | 8 |
| CYTEIR THERAPEUTICS INC | [CYTT](https://holderbook.com/stocks/CYTT/) | $7.0M | 2,459,572 | 15.7% | 8 |
| PMV PHARMACEUTICALS INC | [PMVP](https://holderbook.com/stocks/PMVP/) | $6.1M | 989,232 | 13.7% | 8 |
| GRAPHITE BIO INC | [GRPH](https://holderbook.com/stocks/GRPH/) | $1.0M | 406,308 | 2.3% | 8 |
| SELECTA BIOSCIENCES INC | [RNAC](https://holderbook.com/stocks/RNAC/) | $914.3K | 862,543 | 2.1% | 8 |
| VOR BIOPHARMA INC | [VORXXXX](https://holderbook.com/stocks/VORXXXX/) | $794.4K | 374,714 | 1.8% | 8 |
| EFFECTOR THERAPEUTICS INC | [EFTR](https://holderbook.com/stocks/EFTR/) | $615.3K | 1,025,697 | 1.4% | 8 |
| PRECISION BIOSCIENCES INC | [DTIL](https://holderbook.com/stocks/DTIL/) | $383.6K | 1,123,913 | 0.9% | 8 |
| SPERO THERAPEUTICS INC | [SPRO](https://holderbook.com/stocks/SPRO/) | $301.4K | 249,070 | 0.7% | 8 |
| IKENA ONCOLOGY INC | [IKNA](https://holderbook.com/stocks/IKNA/) | $116.2K | 26,833 | 0.3% | 1 |
| HOMOLOGY MEDICINES INC | [FIXX](https://holderbook.com/stocks/FIXX/) | $74.9K | 64,000 | 0.2% | 8 |

## What the disclosed book did

Not the fund's return. This is the change in value of the positions disclosed on Form 13F, had they been left untouched, against SPY over the same quarter ends.

| Quarter | Book | Market | Difference | Priced |
|---|---|---|---|---|
| Q3 2023 | -3.9% | -3.6% | -0.4% | 79% |
| Q2 2023 | +31.1% | +8.3% | +22.8% | 100% |
| Q1 2023 | -10.3% | +7.0% | -17.3% | 100% |
| Q4 2022 | +8.5% | +7.1% | +1.5% | 100% |
| Q3 2022 | -7.2% | -5.3% | -1.8% | 100% |
| Q2 2022 | -40.5% | -16.5% | -24.0% | 100% |
| Q1 2022 | -32.2% | -4.9% | -27.3% | 100% |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q3 2023 | $44.5M | 12 |
| Q2 2023 | $58.6M | 12 |
| Q1 2023 | $50.1M | 14 |
| Q4 2022 | $61.3M | 14 |
| Q3 2022 | $64.2M | 15 |
| Q2 2022 | $72.7M | 15 |
| Q1 2022 | $131.3M | 16 |
| Q4 2021 | $221.9M | 16 |